Oncostatin M Promotes Mucosal Epithelial Barrier Dysfunction, and Its Expression Is Increased in Patients With Eosinophilic Mucosal Disease

Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2015.01.043
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Perspectives on Mucosal Vaccines: Is Mucosal Tolerance a Barrier?

Journal of Immunology
AllergyImmunology
2007English

Mucosal Immune Barrier System in Human Nasal Epithelial Cells

Nihon Bika Gakkai Kaishi (Japanese Journal of Rhinology)
2010English

Increased Expression of DUOX2 Is an Epithelial Response to Mucosal Dysbiosis Required for Immune Homeostasis in Mouse Intestine

Gastroenterology
HepatologyGastroenterology
2015English

Gene Expression Profiles of Mucosal Biopsy Specimens From Children With Eosinophilic Gastritis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2015English

Altered Esophageal Mucosal Structure in Patients With Celiac Disease

Canadian Journal of Gastroenterology and Hepatology
MedicineHepatologyGastroenterology
2016English

Intra-Abdominal Infection Combined With Intra-Abdominal Hypertension Aggravates the Intestinal Mucosal Barrier Dysfunction

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2018English

Oncostatin M Receptor, Positively Regulated by SP1, Promotes Gastric Cancer Growth and Metastasis Upon Treatment With Oncostatin M

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2019English

Increased P16 and P53 Protein Expression Predicts Poor Prognosis in Mucosal Melanoma

Oncotarget
Oncology
2017English

Usefulness of Physiological Assessment on Membrane Barrier Function in Intestinal Mucosal Disease

Drug Metabolism and Pharmacokinetics
1995English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy